A vector-based cancer vaccine for first-line treatment of asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer.
If you have a Hayes login, click here to view the full report on the Knowledge Center.
A vector-based cancer vaccine for first-line treatment of asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer.
If you have a Hayes login, click here to view the full report on the Knowledge Center.